Protocatechuic acid inhibits lung cancer cells by modulating FAK, MAPK, and NF-κB pathways. [electronic resource]
Producer: 20150805Description: 1331-41 p. digitalISSN:- 1532-7914
- Apoptosis -- drug effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Caspase 3 -- genetics
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Dose-Response Relationship, Drug
- Down-Regulation
- Fibronectins -- genetics
- Focal Adhesion Protein-Tyrosine Kinases -- genetics
- Humans
- Hydroxybenzoates -- pharmacology
- Interleukin-6 -- genetics
- Interleukin-8 -- genetics
- Matrix Metalloproteinase 2 -- genetics
- Matrix Metalloproteinase 9 -- genetics
- Mitogen-Activated Protein Kinases -- genetics
- NF-kappa B -- genetics
- Signal Transduction
- Vascular Endothelial Growth Factor A -- genetics
- bcl-2-Associated X Protein -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.